Physician profile
John P Dickey
NPI 1013203306
$856.68
in general payments reported to CMS, 2019-2025
9 companies · $354 in 2025
The $354 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $28.83 · 2022: $182 · 2023: $53.99 · 2024: $238 · 2025: $354.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $646.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $645.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $530.68 | 2022-2025 | Lifevest |
| Vertex Pharmaceuticals Incorporated | $76.22 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $60.00 | 2024-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $56.26 | 2021-2024 | Xarelto |
| Kestra Medical Technology Services, INC. | $35.34 | 2024 | Assure Wcd |
| Lexicon Pharmaceuticals, INC. | $34.10 | 2023 | Inpefa |
| Angiodynamics, INC. | $28.84 | 2025 | Angiovac |
| Novartis Pharmaceuticals Corporation | $20.81 | 2022 | |
| Pfizer INC. | $14.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Dickey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.